Thoratec HeartMate II Continuous-Flow LVAD Poses “Acceptable” Risks

A new study of Thoratec's HeartMate II continuous-flow left-ventricular assist device supports the growing consensus that patient selection has a far greater influence than device selection on the mortality rate of LVAD patients